RECENT PLACEMENT

Occam Places Wildon Farwell as CMO of Dyne

Occam Places Wildon Farwell as CMO of Dyne

Dyne Therapeutics, an Atlas Investment, is a platform biotech developing therapeutics across neuromuscular indications.


In early 2021, Occam recruited Wildon Farwell, MD as the company’s CMO. Previously, Wildon held a lengthy career at Biogen, having most recently served as the company’s Global Medical Head for Neuromuscular Diseases.

About Occam Global

Occam Global is an executive recruiting and leadership advisory firm with specialties across technological fields including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.